MELANOMA (SKIN)
Clinical trials for MELANOMA (SKIN) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy after surgery shows promise in preventing melanoma return
Disease control CompletedThis study tested the drug nivolumab in 26 people who had surgery for stage IIB or IIC melanoma, a serious skin cancer. The goal was to see if the drug could help keep the cancer from coming back. Nivolumab is a type of immunotherapy that helps the immune system attack cancer cel…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 03:21 UTC
-
Bone drug boosts immunotherapy in advanced melanoma trial
Disease control CompletedThis study tested whether adding denosumab (a bone-strengthening drug) to standard immunotherapy (pembrolizumab or nivolumab) could help control advanced melanoma. 25 adults with stage III or IV melanoma that could not be removed by surgery took part. The goal was to see if denos…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Freeze and fight: new combo tackles Hard-to-Treat melanoma
Disease control CompletedThis early-phase study tested a new approach for stage IIIB/C melanoma that has spread to lymph nodes. Doctors used a freezing technique (cryotherapy) to destroy accessible tumors, then injected the immunotherapy drug ipilimumab directly into the treated area, along with a flat d…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
AI matches dermatologists in spotting deadly melanoma
Diagnosis CompletedThis study tested a computer system that uses artificial intelligence (AI) to spot skin cancer (melanoma) from photos of skin spots. 105 adults with suspicious moles participated. Researchers compared the AI's accuracy to expert dermatologists and lab biopsy results. The goal is …
Matched conditions: MELANOMA (SKIN)
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated May 26, 2026 03:03 UTC
-
Tapping away fear: EFT eases emotional toll for melanoma survivors
Symptom relief CompletedThis study tested Emotional Freedom Techniques (EFT), a type of tapping therapy, in 56 people who had been treated for melanoma and were now in remission. The goal was to see if EFT could reduce negative emotions like anxiety, depression, and fear that the cancer might come back.…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: Soul Medicine Institute • Aim: Symptom relief
Last updated May 26, 2026 03:13 UTC
-
Your DNA vs. the sun: will a genetic warning make you cover up?
Knowledge-focused CompletedThis study looked at whether telling people about their genetic risk for melanoma (a serious skin cancer) would make them more careful in the sun. Over 2,000 adults took part, and researchers tracked things like time in the sun, sunscreen use, and sunburns. The goal was to see if…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 03:09 UTC
-
New study tracks how melanoma patients use a smartphone app during targeted treatment
Knowledge-focused CompletedThis study observed about 400 adults with advanced BRAF-mutant melanoma who were taking targeted therapy (BRAF/MEK inhibitors) and using a smartphone app called TavieSkin. The goal was to describe patient characteristics, how they used the app, and their quality of life. No new t…
Matched conditions: MELANOMA (SKIN)
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC
-
New PET scan tracks immune cells in melanoma patients
Knowledge-focused CompletedThis early-phase study tested a special PET/CT scan that uses a tracer to detect immune cells (CD8+ T cells) in tumors. Six adults with advanced melanoma who were also on immunotherapy and hydroxychloroquine received the scan before and after treatment. The goal was to see if cha…
Matched conditions: MELANOMA (SKIN)
Phase: EARLY_PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC